Langenfeld J - Search Results

1

Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5.

Langenfeld EM, Kong Y, Langenfeld J. Langenfeld EM, et al. Among authors: langenfeld j. Oncogene. 2006 Feb 2;25(5):685-92. doi: 10.1038/sj.onc.1209110. Oncogene. 2006. PMID: 16247476

2

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.

Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. Langenfeld EM, et al. Among authors: langenfeld j. Carcinogenesis. 2003 Sep;24(9):1445-54. doi: 10.1093/carcin/bgg100. Epub 2003 Jun 19. Carcinogenesis. 2003. PMID: 12819188

3

Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.

Langenfeld EM, Langenfeld J. Langenfeld EM, et al. Among authors: langenfeld j. Mol Cancer Res. 2004 Mar;2(3):141-9. Mol Cancer Res. 2004. PMID: 15037653

4

Expression of bone morphogenetic proteins in human lung carcinomas.

Langenfeld EM, Bojnowski J, Perone J, Langenfeld J. Langenfeld EM, et al. Among authors: langenfeld j. Ann Thorac Surg. 2005 Sep;80(3):1028-32. doi: 10.1016/j.athoracsur.2005.03.094. Ann Thorac Surg. 2005. PMID: 16122479

5

Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin.

Langenfeld EM, Kong Y, Langenfeld J. Langenfeld EM, et al. Among authors: langenfeld j. Mol Cancer Res. 2005 Dec;3(12):679-84. doi: 10.1158/1541-7786.MCR-05-0124. Mol Cancer Res. 2005. PMID: 16380505

6

Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by post-transcriptional mechanisms.

Jiang S, Zhang S, Langenfeld J, Lo SC, Rogers MB. Jiang S, et al. Among authors: langenfeld j. J Cell Biochem. 2008 May 15;104(2):580-94. doi: 10.1002/jcb.21647. J Cell Biochem. 2008. PMID: 18059017

7

Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.

Langenfeld E, Hong CC, Lanke G, Langenfeld J. Langenfeld E, et al. Among authors: langenfeld j. PLoS One. 2013 Apr 12;8(4):e61256. doi: 10.1371/journal.pone.0061256. Print 2013. PLoS One. 2013. PMID: 23593444 Free PMC article.

8

Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.

Langenfeld E, Deen M, Zachariah E, Langenfeld J. Langenfeld E, et al. Among authors: langenfeld j. Mol Cancer. 2013 Oct 26;12(1):129. doi: 10.1186/1476-4598-12-129. Mol Cancer. 2013. PMID: 24160469 Free PMC article.

9

Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.

Augeri DJ, Langenfeld E, Castle M, Gilleran JA, Langenfeld J. Augeri DJ, et al. Among authors: langenfeld e, langenfeld j. Mol Cancer. 2016 Apr 6;15:27. doi: 10.1186/s12943-016-0511-9. Mol Cancer. 2016. PMID: 27048361 Free PMC article.

10

Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Newman JH, Augeri DJ, NeMoyer R, Malhotra J, Langenfeld E, Chesson CB, Dobias NS, Lee MJ, Tarabichi S, Jhawar SR, Bommareddy PK, Marshall S, Sadimin ET, Kerrigan JE, Goedken M, Minerowicz C, Jabbour SK, Li S, Carayannopolous MO, Zloza A, Langenfeld J. Newman JH, et al. Among authors: langenfeld e, langenfeld j. Oncogene. 2018 Jul;37(27):3672-3685. doi: 10.1038/s41388-018-0156-9. Epub 2018 Apr 6. Oncogene. 2018. PMID: 29622797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters